What's happening in clinical trials right now?

 

This event focused on clinical trials for mitochondrial disease (mito). It was led by Dr Serge Geara, a neurologist and mitochondrial disease fellow at NeuRA.

This event was recorded on Saturday 1 November 2025, during the Mito Community Summit. Visit our website to listen to or read about this event.

Related resources:

Listen to the audio

Read a summary of the event here

This summary has been automatically generated.

  • Dr. Serge Geara, a neurologist focusing on mitochondrial diseases, discusses the current state of clinical trials for mitochondrial disease, with dozens of trials happening worldwide and more new therapies in development 00:58.
  • Mitochondrial diseases are complex, with multiple mutations affecting people differently, and symptoms can vary greatly between individuals, making it challenging to find effective treatments 02:45.
  • Several medications are being researched, including Elamipretide, which stabilises the mitochondrial membrane, and Bio 101, which targets the map kynise pathway to improve muscle physiology 05:33.
  • Other potential agents, such as KL133, are being investigated for their ability to control lactic acidosis and increase energy levels, with a potential trial awaiting ethics approval 09:08.
  • Researchers are exploring various novel agents, including Ren 001, which aims to train muscles to become better and potentially address muscle symptoms in mitochondrial disease 11:05.
  • Another agent, NV354, is being investigated for its potential to activate the citric acid cycle and increase ATP production, with promising pre-clinical results 12:17.
  • Gene therapy is also being explored as a potential treatment for mitochondrial diseases, using techniques such as viral vectors to deliver genetic material to specific cells 13:03.
  • The Mito Foundation is involved in a natural history study of mitochondrial diseases, collecting samples and clinical information from patients to better understand the progression of the disease and identify potential biomarkers 16:08.
  • Researchers are investigating various medications, including Zagosiguat, which aims to prevent further tissue damage by keeping blood vessels open, and are encouraging patients to ask their doctors about potential trials 17:42.

Disclaimer: Resources provided by the Australian Mitochondrial Disease Foundation Limited (Mito Foundation), offers general information and is not a substitute for medical advice. It is essential to assess the suitability of the content for your individual circumstances and make decisions based on your medical condition. The information's accuracy is subject to change, and we do not guarantee ongoing currency or availability. While efforts are made to ensure accuracy, Mito Foundation is not obligated to provide updated information. The copyright for this document and its content belongs to, or is licensed to, Mito Foundation, and reproduction without prior written consent is prohibited.

More Videos

Link to Understanding Autosomal Dominant Optic Atrophy Video

Understanding Autosomal Dominant Optic Atrophy

View Video

This webinar focused on Autosomal Dominant Optic Atrophy (ADOA), a genetic condition that affects the optic nerve and is a form of mitochondrial disease.

The session explores how ADOA affects vision, how it is diagnosed, the genetics behind the condition, and current research aimed at improving understanding of the disease.

The webinar is hosted by Clare Stuart, Advocacy and Engagement Manager at the Mito Foundation.

This webinar featured speakers including Prof Clare Fraser from the University of Sydney’s Save Sight Institute, Prof David Mackey from the Lions Eye Institute, and A/Prof Owen Siggs from the Garvan Institute of Medical Research.

Note: A segment sharing personal lived experience with ADOA has been removed from this recording.

This event was recorded on 23 February 2026. It is available to watch, listen or read about.

Link to Uncertainty to certainty: mito clinical trials panel Video

Uncertainty to certainty: mito clinical trials panel

View Video

This event focused on clinical trials for mitochondrial disease (mito). It was led by Clare Stuart, Mito Foundation Advocacy and Engagement Manager. Panel members were Lani Quirk, Mito community member, Jessica Stevenson (PYC Therapeutics), Monique Alves (Biogen), Dr Sebastian Lush (NeuRA).

This event was recorded on Saturday 1 November 2025, during the Mito Community Summit. Visit our website to listen to or read about this event.

Link to Mito Webinar: financial consideration for chronic illness Video

Mito Webinar: financial consideration for chronic illness

View Video

Watch Calum Liang, an executive financial advisor from Viridian Advisory, and Laura Barker from the Mito Foundation discuss financial considerations when living with a chronic illness during a Managing Mito Webinar on Thursday 5 September 2024.

Link to Meet the Expert: Professor David Thorburn Video

Meet the Expert: Professor David Thorburn

View Video

This event focused on the diagnosis of mitochondrial disease (mito). It was led by Professor David Thorburn, an experienced researcher in genomic medicine.

This event, was recorded on Monday 16 June 2025. It is available to watch, listen or read about.